← Open Payments lookup

JESSICA MCNEESE: Open Payments

NPI 1770927121 · RUSSELLVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$722 in 37 payments from 12 companies in 2025. Trend: 2023 $642 · 2024 $570 · 2025 $722

Food & beverage: $722
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$159
Novo Nordisk Inc8$129
Axsome Therapeutics, Inc.6$120
ABBVIE INC.3$88
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$82
Otsuka America Pharmaceutical, Inc.2$32
Xeris Pharmaceuticals, Inc.1$25
Abbott Laboratories1$24
Amgen Inc.1$17
PFIZER INC.1$17

Products named: Auvelity, AIRSUPRA, Ozempic, CAPLYTA, VRAYLAR, BREZTRI, REXULTI, KEVEYIS.

Industry payments across AR — which companies pay providers there.